Cover Image

OP 6.4 - 00096 High-efficiency CRISPR/Cas9-mediated disruption of ccr5 in human hematopoietic stem progenitor cells generates HIV-refractory immune systems

Saved in:

Bibliographic Details
Main Authors:	D. Claiborne (Author), Z. Detwiler (Author), K. Okawa (Author), T. Bateson (Author), T. Chen (Author), D. Scadden (Author), C. Boutwell (Author), T. Allen (Author)
Format:	Book
Published:	Elsevier, 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CCR5 Disruption in Induced Pluripotent Stem Cells Using CRISPR/Cas9 Provides Selective Resistance of Immune Cells to CCR5-tropic HIV-1 Virus
by: HyunJun Kang, et al.
Published: (2015)

Hepatic stellate cell reprogramming via exosome-mediated CRISPR/dCas9-VP64 delivery
by: Nianan Luo, et al.
Published: (2021)

CCR5- and CXCR4-tropic HIVs infect CD4+ hematopoietic stem and progenitor cells in vitro and in optimally treated people
by: N. Sebastian, et al.
Published: (2015)

Lineage reprogramming of fibroblasts into induced cardiac progenitor cells by CRISPR/Cas9-based transcriptional activators
by: Jianglin Wang, et al.
Published: (2020)

OP 2.1 CCR5 in HIV Prevention and Cure
by: Helen L. Wu, et al.
Published: (2022)

Priming Human Repopulating Hematopoietic Stem and Progenitor Cells for Cas9/sgRNA Gene Targeting
by: Carsten T. Charlesworth, et al.
Published: (2018)

PP 6.3 - 00178 Targeting the human and macaque CCR5 genes using the CRISPR-SaCas9 gene-editing platform
by: M. Caocci, et al.
Published: (2022)

High Efficiency Gene Correction in Hematopoietic Cells by Donor-Template-Free CRISPR/Cas9 Genome Editing
by: Duran Sürün, et al.
Published: (2018)

CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer's Disease
by: Bence György, et al.
Published: (2018)

The Impact of CRISPR-Cas System on Antiviral Therapy
by: Hadi Bayat, et al.
Published: (2018)

Application of CRISPR/Cas9 in plant biology
by: Xuan Liu, et al.
Published: (2017)

TREX2 enables efficient genome disruption mediated by paired CRISPR-Cas9 nickases that generate 3'-overhanging ends
by: Yue Wang, et al.
Published: (2023)

CRISPR/Cas9 Genome Editing in LGMD2A/R1 Patient-Derived Induced Pluripotent Stem and Skeletal Muscle Progenitor Cells
by: Lampros Mavrommatis, et al.
Published: (2023)

Principles and medical applications of gene editing by CRISPR / Cas
by: Rolando Sánchez Artigas, et al.
Published: (2021)

Optimization of CRISPR-Cas system for clinical cancer therapy
by: Xiang Meng, et al.
Published: (2023)

CRISPR/Cas9: Transcending the Reality of Genome Editing
by: Sergiu Chira, et al.
Published: (2017)

CRISPR/Cas-based CAR-T cells: production and application
by: Ping Song, et al.
Published: (2024)

Targeting Hepatitis B Virus With CRISPR/Cas9
by: Christoph Seeger, et al.
Published: (2014)

The CRISPR/Cas9 System Delivered by Extracellular Vesicles
by: Xinglong Zhu, et al.
Published: (2023)

Generation of desminopathy in rats using CRISPR‐Cas9
by: Henning T. Langer, et al.
Published: (2020)

The Rise of CRISPR/Cas for Genome Editing in Stem Cells
by: Bing Shui, et al.
Published: (2016)

Bioinformatics investigation of CRISPR/Cas systems in Bifidobacterium longum
by: Amir Zarrinhaghighi, et al.
Published: (2021)

Inducing CCR5Δ32/Δ32 Homozygotes in the Human Jurkat CD4+ Cell Line and Primary CD4+ Cells by CRISPR-Cas9 Genome-Editing Technology
by: Chunxia Qi, et al.
Published: (2018)

CRISPR-Cas9 mediated phage therapy as an alternative to antibiotics
by: Fikre Birhanu Balcha, et al.
Published: (2023)

CRISPR-Cas13a Inhibits HIV-1 Infection
by: Lijuan Yin, et al.
Published: (2020)

CRISPR/Cas9 systems: Delivery technologies and biomedical applications
by: Yimin Du, et al.
Published: (2023)

Overcoming the Undesirable CRISPR-Cas9 Expression in Gene Correction
by: Emily Xia, et al.
Published: (2018)

Immunotherapy and CRISPR Cas Systems: Potential Cure of COVID-19?
by: He X, et al.
Published: (2022)

CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
by: Wei-Jing Dai, et al.
Published: (2016)

Correction: CRISPR/Cas-based CAR-T cells: production and application
by: Ping Song, et al.
Published: (2024)

In vivo delivery of CRISPR-Cas9 therapeutics: Progress and challenges
by: Matthew Behr, et al.
Published: (2021)

CRISPR-Cas9 delivery strategies with engineered extracellular vesicles
by: Yaoyao Lu, et al.
Published: (2023)

Advances in Chitosan-Based CRISPR/Cas9 Delivery Systems
by: Anna E. Caprifico, et al.
Published: (2022)

Nanovesicle-Mediated Delivery Systems for CRISPR/Cas Genome Editing
by: Dongyoon Kim, et al.
Published: (2020)

Novel Epigenetic Techniques Provided by the CRISPR/Cas9 System
by: Nina Xie, et al.
Published: (2018)

CRISPR/Cas9-mediated genome editing in nonhuman primates
by: Yu Kang, et al.
Published: (2019)

Engineering miniature CRISPR-Cas Un1Cas12f1 for efficient base editing
by: Yueer Hu, et al.
Published: (2024)

CRISPR-Cas9‒Based Genomic Engineering in Keratinocytes: From Technology to Application
by: Jos P.H. Smits, et al.
Published: (2022)

Natural Biopolymer-Based Delivery of CRISPR/Cas9 for Cancer Treatment
by: Meng Lin, et al.
Published: (2023)

Genome-wide CRISPR/Cas9 screening for drug resistance in tumors
by: Zhongyan Zhang, et al.
Published: (2023)